BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 9057510)

  • 1. Endometrial thickness in tamoxifen-treated patients: correlation with clinical and pathologic findings.
    Hann LE; Giess CS; Bach AM; Tao Y; Baum HJ; Barakat RR
    AJR Am J Roentgenol; 1997 Mar; 168(3):657-61. PubMed ID: 9057510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen and progesterone receptor expression in postmenopausal tamoxifen-exposed endometrial pathologies.
    Cohen I; Beyth Y; Altaras MM; Shapira J; Tepper R; Cardoba M; Yigael D; Figer A; Fishman A; Berenhein J
    Gynecol Oncol; 1997 Oct; 67(1):8-15. PubMed ID: 9345349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of endometrial changes among symptomatic tamoxifen-treated and nontreated premenopausal and postmenopausal breast cancer patients.
    Cheng WF; Lin HH; Torng PL; Huang SC
    Gynecol Oncol; 1997 Aug; 66(2):233-7. PubMed ID: 9264568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in serum estrogen levels in women during tamoxifen therapy.
    Lum SS; Woltering EA; Fletcher WS; Pommier RF
    Am J Surg; 1997 May; 173(5):399-402. PubMed ID: 9168075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of polypoid endometriosis mimicking advanced ovarian carcinoma with rapid growth, invasion, and dissemination.
    Yazawa H; Yazawa R; Fukuda K; Ohara M
    Fukushima J Med Sci; 2022 Dec; 68(3):183-190. PubMed ID: 36288947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Machine Learning for Endometrial Cancer Prediction and Prognostication.
    Bhardwaj V; Sharma A; Parambath SV; Gul I; Zhang X; Lobie PE; Qin P; Pandey V
    Front Oncol; 2022; 12():852746. PubMed ID: 35965548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endometrial Surveillance in Tamoxifen and Letrozole Treated Breast Cancer Patients.
    AlZaabi A; AlAmri H; ALAjmi G; Allawati M; Muhanna F; Alabri R; AlBusaidi F; AlGhafri S; Al-Mirza AA; Al Baimani K
    Cureus; 2021 Nov; 13(11):e20030. PubMed ID: 34987915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thickened Endometrium: When to Intervene? A Clinical Conundrum.
    Giri SK; Nayak BL; Mohapatra J
    J Obstet Gynaecol India; 2021 Jun; 71(3):216-225. PubMed ID: 34408340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI of the endometrium - from normal appearances to rare pathology.
    Pintican R; Bura V; Zerunian M; Smith J; Addley H; Freeman S; Caruso D; Laghi A; Sala E; Jimenez-Linan M
    Br J Radiol; 2021 Sep; 94(1125):20201347. PubMed ID: 34233457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polypoid endometriosis: a mimic of malignancy.
    Ghafoor S; Lakhman Y; Park KJ; Petkovska I
    Abdom Radiol (NY); 2020 Jun; 45(6):1776-1782. PubMed ID: 31372776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Study on Hysteroscopic and Histologic Examinations of the Endometrium in Postmenopausal Women Taking Tamoxifen.
    Jung H; Jung JK; Kim SB; Cho EA; Um MJ
    J Menopausal Med; 2018 Aug; 24(2):81-86. PubMed ID: 30202756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tamoxifen Therapy for Breast Cancer and Endometrial Pathology.
    Kochar S; Arora P; Chattopadhyay AB
    Med J Armed Forces India; 2005 Oct; 61(4):313-5. PubMed ID: 27407795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic options for management of endometrial hyperplasia.
    Chandra V; Kim JJ; Benbrook DM; Dwivedi A; Rai R
    J Gynecol Oncol; 2016 Jan; 27(1):e8. PubMed ID: 26463434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of endometrium in peri-menopausal abnormal uterine bleeding.
    Kotdawala P; Kotdawala S; Nagar N
    J Midlife Health; 2013 Jan; 4(1):16-21. PubMed ID: 23833528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endometrial pathology in breast cancer patients: Effect of different treatments on ultrasonographic, hysteroscopic and histological findings.
    LE Donne M; Alibrandi A; Ciancimino L; Azzerboni A; Chiofalo B; Triolo O
    Oncol Lett; 2013 Apr; 5(4):1305-1310. PubMed ID: 23599784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gynecologic care for breast cancer survivors: assisting in the transition to wellness.
    Salani R; Andersen BL
    Am J Obstet Gynecol; 2012 May; 206(5):390-7. PubMed ID: 22177185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of tamoxifen on the genital tract.
    Polin SA; Ascher SM
    Cancer Imaging; 2008 Jun; 8(1):135-45. PubMed ID: 18603495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in the endometrium after tamoxifen therapy].
    Schmidt D
    Pathologe; 2006 Feb; 27(1):27-32. PubMed ID: 16362260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective estrogen receptor modulators: tissue actions and potential for CNS protection.
    Littleton-Kearney MT; Ostrowski NL; Cox DA; Rossberg MI; Hurn PD
    CNS Drug Rev; 2002; 8(3):309-30. PubMed ID: 12353060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endometrial pathology in postmenopausal tamoxifen treatment: comparison between gynaecologically symptomatic and asymptomatic breast cancer patients.
    Cohen I; Perel E; Flex D; Tepper R; Altaras MM; Cordoba M; Beyth Y
    J Clin Pathol; 1999 Apr; 52(4):278-82. PubMed ID: 10474520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.